Weight Loss Prescription Drugs Belviq

The exception is orlistat.
Weight loss prescription drugs belviq. Belviq is also approved for use by adults with a bmi of 27 or greater and who have at least one weight related condition such as high blood pressure. Keep taking any other medications your doctor has prescribed to treat these conditions. Weight loss during pregnancy can harm an unborn baby even if you are overweight.
The weight loss medicine belviq might be associated with an increased risk of cancer fda says the fda or the us food and drug administration warns the public that the prescription weight loss. It works by interfering with absorption of fat. Some weight loss drugs contain a stimulant medication and are classified as controlled substances by the drug enforcement agency dea.
Most prescription weight loss drugs work by decreasing appetite or increasing feelings of fullness. Most weight loss drugs that suppress the appetite are known as anorexiants. Naltrexone is used to treat alcohol and opioid dependence.
27 2018 healthday news the weight loss drug belviq lorcaserin appears to help people shed pounds without adversely affecting the heart in those already at higher heart risk. Bupropion naltrexone is a combination drug. The fda s february 13 2020 drug safety communication advises patients to stop taking belviq and belviq xr and talk to their health care professional about alternative weight loss medications and weight management programs.
The table below lists fda approved prescription medications for weight loss. Belviq will not treat any underlying health condition such as heart disease diabetes high blood pressure. User reviews for belviq to treat weight loss belviq has an average rating of 7 6 out of 10 from a total of 582 ratings for the treatment of weight loss.
The fda has approved five of these drugs orlistat xenical alli lorcaserin belviq phentermine topiramate qsymia naltrexone bupropion contrave and liraglutide saxenda for long term use. 69 of those users who reviewed belviq reported a positive effect while 19 reported a negative effect. In 2012 the fda approved the first two new weight loss drugs in over a decade belviq and qsymia.